RhumbLine Advisers’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$505K Sell
55,278
-546
-1% -$4.58K ﹤0.01% 2607
2025
Q4
$415K Sell
55,824
-8,451
-13% -$60.7K ﹤0.01% 2786
2025
Q3
$430K Sell
64,275
-818
-1% -$5.68K ﹤0.01% 2794
2025
Q2
$431K Buy
65,093
+11,133
+21% +$78.9K ﹤0.01% 2780
2025
Q1
$494K Sell
53,960
-873
-2% -$8.72K ﹤0.01% 2584
2024
Q4
$576K Buy
54,833
+297
+0.5% +$3.51K ﹤0.01% 2585
2024
Q3
$652K Buy
54,536
+2,099
+4% +$18.1K ﹤0.01% 2529
2024
Q2
$302K Buy
52,437
+51,478
+5,368% +$282K ﹤0.01% 3001
2024
Q1
$4.99K Hold
959
﹤0.01% 3985
2023
Q4
$5.05K Hold
959
﹤0.01% 3983
2023
Q3
$3.16K Sell
959
-3,817
-80% -$13.4K ﹤0.01% 4051
2023
Q2
$13.8K Sell
4,776
-43,000
-90% -$82.5K ﹤0.01% 3871
2023
Q1
$51K Buy
47,776
+277
+0.6% +$530 ﹤0.01% 2905
2022
Q4
$124K Buy
47,499
+156
+0.3% +$681 ﹤0.01% 2878
2022
Q3
$331K Buy
47,343
+2,626
+6% +$20.6K ﹤0.01% 2687
2022
Q2
$305K Buy
44,717
+16,517
+59% +$169K ﹤0.01% 2743
2022
Q1
$398K Buy
28,200
+8,055
+40% +$108K ﹤0.01% 2523
2021
Q4
$292K Buy
+20,145
New +$286K ﹤0.01% 2713

Other funds holding BVS